To The Moon

$Adtran(ADTN)$ bought in as the prices dropped in 2023-2024 as rising interest rates eroded the profitability of capital intensive companies. But a business like Adtran's, critical to the interconnectivity that underpins the latest innovations driving the growth of our society, can't possibly turn bad overnight. It feels like a long 1.5 year journey, and I'm glad I've held on till now [Victory] [Wow]  

Bumping this for the community! Hope Tiger listens [Grin] [Grin] [Grin]  

I missed the previous TigerGpt campaign for new features we want to see, but I just thought of one and I hope @TigerBrokers agrees! I hope TigerGPT allows for its results to be read out loud! Having @TigerGPT "talk back" to us would really make it accessible and personal [Love you]   What do you guys think?

$Aureus Greenway Holdings Inc.(AGH)$  Company Profile (taken from company's website) We, Aureus Greenway Holdings Inc., a Nevada holding company, own and operate two public golf country clubs, Kissimmee Bay Country Club and Remington Golf Club. Both clubs are located just south of Orlando, Florida. The golf country clubs are situated on a combined 289 acres of multi-service recreational property. Our golf country clubs include two 18-hole golf-courses with over 13,000 yards of combined fairways and clubhouses boasting food and beverage options, aquatic golf ranges and pro shops to assist any level of golfers. Our golf country clubs regularly host local golf leagues, golf-tournaments, and private events. Our golf country clubs are a serene

$Workday(WDAY)$  In the lead up to its latest earnings, its price has been depressed. RSI6 was hovering in the 30s, very close to being oversold. This dip seems to be macro-influenced rather than being a company specific movement. With a track record of 10 consecutive quarters of earnings beat, and having heard no negative news or sentiment against the company's future outlook, I decided to enter a position for the price to bounce back up above $260 after earnings were released. $WDAY VERTICAL 250307 CALL 260.0/CALL 267.5$  This time, unlike with $Berkshire Hathaway(BRK

Bought $AstraZeneca PLC(AZN)$  last year when its price dipped close to $65. Felt like it was quite undervalued back then, and it was being pulled down by the negative market perception of healthcare as a whole. AZN's strength was still its array of valuable product for a range of healthcare issues, and without any negative factor such as patent expiry in the near future, it didn't warrant the dip in price seen near the end of last year. Now with the strength of its previous quarter earnings, and fueled by a growth outlook with this piece of news: "AstraZeneca (AZN.L), opens new tab will buy longtime partner FibroGen's (FGEN.O), opens new tab China unit for about $160 million to gain rights to its anemia drug in the c

Although I believed $Berkshire Hathaway(BRK.B)$ would bounce up after Earnings Weekend, breaking $500 was a surprise to me! If you don't have much capital to deploy, buying 1 share last Friday would net you ~$25. Buying a naked call option or selling a put option are two ways to earn more money, but they either require a significant amount of capital (relative to buying 1 share), or they're risky, or both! What I did instead was buy a vertical. A vertical call is when you buy an option at a certain strike price while simultaneously selling another option with the same expiry at a more out-of-money strike price. I entered this $BRK.B VE

Great article, would you like to share it?

Great article, would you like to share it?

Great article, would you like to share it?